(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 8.44% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Caribou Biosciences's revenue in 2025 is $9,295,000.On average, 9 Wall Street analysts forecast CRBU's revenue for 2025 to be $920,566,706, with the lowest CRBU revenue forecast at $824,388,095, and the highest CRBU revenue forecast at $981,414,399. On average, 9 Wall Street analysts forecast CRBU's revenue for 2026 to be $966,272,577, with the lowest CRBU revenue forecast at $852,802,379, and the highest CRBU revenue forecast at $1,128,626,559.
In 2027, CRBU is forecast to generate $1,132,645,684 in revenue, with the lowest revenue forecast at $861,307,970 and the highest revenue forecast at $1,472,121,599.